Company Filing History:
Years Active: 2002
Title: Shilu Wu: Innovator in Human Papillomavirus Vaccine Development
Introduction
Shilu Wu is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of vaccine development, particularly in the area of human papillomavirus (HPV). His innovative work focuses on improving the properties of virus-like particles (VLPs) used in vaccine formulations.
Latest Patents
Shilu Wu holds a patent for a process that enhances the stability and efficacy of human papillomavirus virus-like particles. The patent, titled "Process for making human papillomavirus virus-like particles with improved properties," describes a method where VLPs are subjected to various maturation conditions. These conditions include incubation at higher temperatures and exposure to soluble metals or thios-oxidation. The resultant matured VLPs exhibit increased stability, making them suitable for vaccine formulations with a longer shelf life and higher potency. He has 1 patent to his name.
Career Highlights
Shilu Wu is currently employed at Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to groundbreaking research in vaccine technology. His expertise in the field has positioned him as a valuable asset to the company and the scientific community.
Collaborations
Shilu Wu has collaborated with esteemed colleagues, including Qinjian Zhao and Walter E Manger. These partnerships have fostered a collaborative environment that enhances the research and development of innovative vaccine solutions.
Conclusion
Shilu Wu's contributions to the field of vaccine development, particularly in enhancing the properties of human papillomavirus virus-like particles, demonstrate his commitment to advancing public health. His work at Merck & Co., Inc. and his collaborations with fellow researchers highlight the importance of innovation in the fight against infectious diseases.